Immune Response Profiles of Calves Following Vaccination with Live BCG and Inactivated Mycobacterium Bovis Vaccine Candidates

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Nov 21

PMID 29155877

Citations 10

Authors

E M D L van der Heijden

J Chileshe

J C M Vernooij

C Gortazar

R A Juste

I Sevilla

J E Crafford

V P M G Rutten

A L Michel

Affiliations

Soon will be listed here.

Abstract

Conventional control and eradication strategies for bovine tuberculosis (BTB) face tremendous difficulties in developing countries; countries with wildlife reservoirs, a complex wildlife-livestock-human interface or a lack of veterinary and veterinary public health surveillance. Vaccination of cattle and other species might in some cases provide the only suitable control strategy for BTB, while in others it may supplement existing test-and-slaughter schemes. However, the use of live BCG has several limitations and the global rise of HIV/AIDS infections has furthermore warranted the exploration of inactivated vaccine preparations. The aim of this study was to compare the immune response profiles in response to parenteral vaccination with live BCG and two inactivated vaccine candidates in cattle. Twenty-four mixed breed calves (Bos taurus) aged 4-6 months, were allocated to one of four groups and vaccinated sub-cutaneously with live M. bovis BCG (Danish 1331), formalin-inactivated M. bovis BCG, heat-killed M. bovis or PBS/Montanide™ (control). Interferon-γ responsiveness and antibody production were measured prior to vaccination and at weekly intervals thereafter for twelve weeks. At nine weeks post-priming, animals were skin tested using tuberculins and MTBC specific protein cocktails and subsequently challenged through intranodular injection of live M. bovis BCG. The animals in the heat-killed M. bovis group demonstrated strong and sustained cell-mediated and humoral immune responses, significantly higher than the control group in response to vaccination, which may indicate a protective immune profile. Animals in this group showed reactivity to the skin test reagents, confirming good vaccine take. Lastly, although not statistically significant, recovery of BCG after challenge was lowest in the heat-killed M. bovis group. In conclusion, the parenteral heat-killed M. bovis vaccine proved to be clearly immunogenic in cattle in the present study, urging further evaluation of the vaccine in challenge studies using virulent M. bovis and assessment of vaccine efficacy in field conditions.

Citing Articles

Anti-phenolic glycolipid antibodies in infected cattle.

Zhou Z, van Hooij A, van Dijk J, Musch N, Pierneef L, Khalid H One Health. 2025; 20:100982.

PMID: 39974705 PMC: 11835577. DOI: 10.1016/j.onehlt.2025.100982.

Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens.

Cuenca-Lara P, Blay-Benach M, Cervera Z, Melgarejo C, Moraleda J, Sevilla I Front Vet Sci. 2025; 11:1524461.

PMID: 39931351 PMC: 11809442. DOI: 10.3389/fvets.2024.1524461.

Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis.

Niroula N, Ghodasara P, Marreros N, Fuller B, Sanderson H, Zriba S Sci Rep. 2025; 15(1):3764.

PMID: 39885300 PMC: 11782570. DOI: 10.1038/s41598-025-88176-0.

Dosage and organic acid residue of myelin oligodendrocyte glycoprotein peptide influences immunopathology and development of Bacillus Calmette-Guérin induced experimental autoimmune encephalomyelitis.

Han X, Wang Y, Zhang K, Na T, Wu T, Hao X Exp Anim. 2024; 74(1):16-30.

PMID: 38987201 PMC: 11742474. DOI: 10.1538/expanim.24-0012.

Will we ever eradicate animal tuberculosis?.

Gortazar C, de la Fuente J, Perello A, Dominguez L Ir Vet J. 2023; 76(Suppl 1):24.

PMID: 37737206 PMC: 10515422. DOI: 10.1186/s13620-023-00254-9.

References

Whelan A, Wright D, Chambers M, Singh M, Hewinson R, Vordermeier H . Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine. 2007; 26(2):166-73. DOI: 10.1016/j.vaccine.2007.11.005. View

Shimokata K, Kawachi H, Kishimoto H, Maeda F, Ito Y . Local cellular immunity in tuberculous pleurisy. Am Rev Respir Dis. 1982; 126(5):822-4. DOI: 10.1164/arrd.1982.126.5.822. View

Vordermeier M, Hewinson R . Development of cattle TB vaccines in the UK. Vet Immunol Immunopathol. 2006; 112(1-2):38-48. DOI: 10.1016/j.vetimm.2006.03.010. View

Buddle B, Wedlock D, Denis M . Progress in the development of tuberculosis vaccines for cattle and wildlife. Vet Microbiol. 2005; 112(2-4):191-200. DOI: 10.1016/j.vetmic.2005.11.027. View

Beltran-Beck B, de la Fuente J, Garrido J, Aranaz A, Sevilla I, Villar M . Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis. PLoS One. 2014; 9(5):e98048. PMC: 4026474. DOI: 10.1371/journal.pone.0098048. View

Vordermeier H, Perez de Val B, Buddle B, Villarreal-Ramos B, Jones G, Hewinson R . Vaccination of domestic animals against tuberculosis: review of progress and contributions to the field of the TBSTEP project. Res Vet Sci. 2014; 97 Suppl:S53-60. DOI: 10.1016/j.rvsc.2014.04.015. View

Hewinson R, Vordermeier H, Buddle B . Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis (Edinb). 2003; 83(1-3):119-30. DOI: 10.1016/s1472-9792(02)00062-8. View

Pym A, Brodin P, Brosch R, Huerre M, Cole S . Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002; 46(3):709-17. DOI: 10.1046/j.1365-2958.2002.03237.x. View

Rasmussen P, Rosenkrands I, Andersen P, Gicquel B . A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology (Reading). 1998; 144 ( Pt 11):3195-3203. DOI: 10.1099/00221287-144-11-3195. View

10.

Michel A, Muller B, van Helden P . Mycobacterium bovis at the animal-human interface: a problem, or not?. Vet Microbiol. 2009; 140(3-4):371-81. DOI: 10.1016/j.vetmic.2009.08.029. View

11.

Villarreal-Ramos B, Berg S, Chamberlain L, McShane H, Hewinson R, Clifford D . Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle. Vaccine. 2014; 32(43):5645-9. PMC: 5441994. DOI: 10.1016/j.vaccine.2014.08.009. View

12.

Fitzgerald S, Kaneene J . Wildlife reservoirs of bovine tuberculosis worldwide: hosts, pathology, surveillance, and control. Vet Pathol. 2012; 50(3):488-99. DOI: 10.1177/0300985812467472. View

13.

Garrido J, Sevilla I, Beltran-Beck B, Minguijon E, Ballesteros C, Galindo R . Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS One. 2011; 6(9):e24905. PMC: 3173485. DOI: 10.1371/journal.pone.0024905. View

14.

Mahairas G, Sabo P, Hickey M, Singh D, Stover C . Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996; 178(5):1274-82. PMC: 177799. DOI: 10.1128/jb.178.5.1274-1282.1996. View

15.

Buddle B, Pollock J, Skinner M, Wedlock D . Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens. Int J Parasitol. 2003; 33(5-6):555-66. DOI: 10.1016/s0020-7519(03)00060-2. View

16.

Fine P . Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995; 346(8986):1339-45. DOI: 10.1016/s0140-6736(95)92348-9. View

17.

de la Rua-Domenech R, Goodchild A, Vordermeier H, Hewinson R, Christiansen K, Clifton-Hadley R . Ante mortem diagnosis of tuberculosis in cattle: a review of the tuberculin tests, gamma-interferon assay and other ancillary diagnostic techniques. Res Vet Sci. 2006; 81(2):190-210. DOI: 10.1016/j.rvsc.2005.11.005. View

18.

Michel A, Cooper D, Jooste J, de Klerk L, Jolles A . Approaches towards optimising the gamma interferon assay for diagnosing Mycobacterium bovis infection in African buffalo (Syncerus caffer). Prev Vet Med. 2010; 98(2-3):142-51. DOI: 10.1016/j.prevetmed.2010.10.016. View

19.

Juste R, Alonso-Hearn M, Garrido J, Abendano N, Sevilla I, Gortazar C . Increased Lytic Efficiency of Bovine Macrophages Trained with Killed Mycobacteria. PLoS One. 2016; 11(11):e0165607. PMC: 5098821. DOI: 10.1371/journal.pone.0165607. View

20.

Warren R, Gey van Pittius N, Barnard M, Hesseling A, Engelke E, De Kock M . Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis. 2006; 10(7):818-22. View